Total Payments
$8,152
2024 Payments
$703.70
Companies
19
Transactions
69
Medicare Patients
196
Medicare Billing
$36,707
Payment Breakdown by Category
Consulting$5,600 (68.7%)
Food & Beverage$1,706 (20.9%)
Travel$846.05 (10.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $5,600 | 1 | 68.7% |
| Food and Beverage | $1,706 | 66 | 20.9% |
| Travel and Lodging | $846.05 | 2 | 10.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SERVIER PHARMACEUTICALS LLC | $6,530 | 5 | $0 (2024) |
| Novocure Inc. | $759.54 | 11 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $310.59 | 20 | $0 (2024) |
| UCB, Inc. | $90.34 | 5 | $0 (2024) |
| Lundbeck LLC | $67.98 | 4 | $0 (2024) |
| ABBVIE INC. | $64.73 | 4 | $0 (2024) |
| Lilly USA, LLC | $50.01 | 3 | $0 (2024) |
| SK Life Science, Inc. | $49.82 | 3 | $0 (2024) |
| Neurelis, Inc. | $47.45 | 3 | $0 (2024) |
| IMPEL PHARMACEUTICALS INC. | $30.24 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $703.70 | 43 | Teva Pharmaceuticals USA, Inc. ($233.55) |
| 2023 | $6,791 | 18 | SERVIER PHARMACEUTICALS LLC ($6,514) |
| 2022 | $249.74 | 4 | Novocure Inc. ($249.74) |
| 2021 | $407.13 | 4 | Novocure Inc. ($407.13) |
All Payment Transactions
69 individual payment records from CMS Open Payments — Page 2 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/05/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Neurology | ||||||
| 06/26/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Central Nervous System | ||||||
| 06/13/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $30.29 | General |
| Category: Central Nervous System | ||||||
| 06/11/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $15.96 | General |
| Category: NEUROLOGY | ||||||
| 05/09/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Central Nervous System | ||||||
| 05/08/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: NEUROLOGY | ||||||
| 05/02/2024 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $14.71 | General |
| Category: Oncology | ||||||
| 05/01/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Neurology | ||||||
| 04/29/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Central Nervous System | ||||||
| 04/24/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Central Nervous System | ||||||
| 04/16/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $16.97 | General |
| Category: NEUROLOGY | ||||||
| 03/06/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Neurology | ||||||
| 02/16/2024 | Amylyx Pharmaceuticals, Inc. | RELYVRIO (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: NEUROLOGY | ||||||
| 02/08/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Central Nervous System | ||||||
| 02/08/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: NEUROSCIENCE | ||||||
| 01/30/2024 | Merck Sharp & Dohme LLC | WELIREG (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: ONCOLOGY | ||||||
| 01/23/2024 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: NEUROLOGY | ||||||
| 01/08/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Central Nervous System | ||||||
| 12/18/2023 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | Cash or cash equivalent | $13.54 | General |
| Category: Neurology | ||||||
| 12/12/2023 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | Cash or cash equivalent | $16.70 | General |
| Category: Neurology | ||||||
| 12/11/2023 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Neuroscience | ||||||
| 11/29/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Central Nervous System | ||||||
| 11/09/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Central Nervous System | ||||||
| 10/16/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: NEUROSCIENCE | ||||||
| 09/29/2023 | SERVIER PHARMACEUTICALS LLC | — | Consulting Fee | Cash or cash equivalent | $5,600.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 76 | 177 | $83,875 | $20,492 |
| 2022 | 6 | 120 | 148 | $53,828 | $16,215 |
Total Patients
196
Total Services
325
Medicare Billing
$36,707
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 26 | 80 | $27,955 | $7,934 | 28.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 43 | $26,010 | $6,331 | 24.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 15 | 24 | $22,285 | $4,249 | 19.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 30 | $7,625 | $1,978 | 25.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 32 | 48 | $13,408 | $4,124 | 30.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 23 | 24 | $12,936 | $3,792 | 29.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 23 | 23 | $11,579 | $3,482 | 30.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 13 | 16 | $6,412 | $1,896 | 29.6% |
| 99356 | Extended inpatient or observation hospital service, first hour | Facility | 2022 | 15 | 23 | $5,715 | $1,790 | 31.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 14 | 14 | $3,778 | $1,132 | 30.0% |
About Shama Farooq
Shama Farooq is a Neurology healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/15/2015. The National Provider Identifier (NPI) number assigned to this provider is 1922494087.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Shama Farooq has received a total of $8,152 in payments from pharmaceutical and medical device companies, with $703.70 received in 2024. These payments were reported across 69 transactions from 19 companies. The most common payment nature is "Consulting Fee" ($5,600).
As a Medicare-enrolled provider, Farooq has provided services to 196 Medicare beneficiaries, totaling 325 services with total Medicare billing of $36,707. Data is available for 2 years (2022–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Student in an Organized Health Care Education/Training Program, Neurology
- Location Boston, MA
- Active Since 04/15/2015
- Last Updated 05/14/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1922494087
Products in Payments
- Optune (Device) $700.89
- AJOVY (Biological) $188.42
- Austedo XR (Drug) $108.01
- Briviact (Drug) $71.52
- VYEPTI (Biological) $67.98
- EMGALITY (Drug) $50.01
- UBRELVY (Drug) $49.78
- VALTOCO (Drug) $47.45
- Trudhesa (Drug) $30.24
- NURTEC ODT (Drug) $19.00
- Fintepla (Drug) $18.82
- RELYVRIO (Drug) $18.79
- SMARTVEST (Device) $18.22
- Vitrakvi (Drug) $17.18
- RYTARY (Drug) $16.87
- WELIREG (Drug) $16.37
- Voranigo (Drug) $16.20
- NUEDEXTA (Drug) $14.99
- INGREZZA (Drug) $14.96
- DUOPA (Drug) $14.95
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Boston
Christopher Wright, Md, MD
Neurology — Payments: $2.0M
Neurology $2.0M
Dr. Alfred Sandrock, Md Phd, MD PHD
Neurology — Payments: $1.2M
Neurology $1.2M
Thomas Scammell, M.d, M.D
Neurology — Payments: $598,925
Neurology $598,925
Patrick Wen, Md, MD
Neurology — Payments: $583,963
Neurology $583,963
Dr. Michael Levy, M.d., Ph.d, M.D., PH.D
Neurology — Payments: $519,354
Neurology $519,354
Roy Freeman, M.d, M.D
Neurology — Payments: $489,143
Neurology $489,143